{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:59:46Z","timestamp":1791957586270,"version":"4.3.4"},"reference-count":17,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This evidence\u2010 and consensus\u2010based guideline for the treatment of acne was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. This guideline is an update of the 2016 version. This is a short summary of the full version of the EuroGuiDerm Evidence\u2010based Guideline for the Treatment of Acne. For the complete guideline text, detailed methods report, and comprehensive evidence report, please refer to the online full version. In this targeted update, the guideline group prioritized three key clinical questions considered most relevant for current practice:\n                    <jats:list>\n                      <jats:list-item>\n                        <jats:p>(a) For which types of acne and patient groups should isotretinoin be recommended versus systemic antibiotics, and with what strength of recommendation? (b) What is the appropriate duration for systemic antibiotic therapy?<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>For which types of acne and patient groups should hormonal treatments and spironolactone be recommended, and with what strength of recommendation?<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>For which types of acne and patient groups should new topical treatments, including trifarotene and clascoterone, be recommended and with what strength of recommendation?<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:p>\n                  <jats:p>Additionally, the updated guideline provides revised recommendations regarding: safety of benzoyl peroxide (BPO), selection of systemic antibiotic therapy, treatment considerations during pregnancy, isotretinoin dosing strategies, and the use of hormonal antiandrogenic contraceptives or other combined hormonal contraceptives, as well as spironolactone. All other aspects remain unchanged from the 2016 guideline.<\/jats:p>","DOI":"10.1111\/jdv.70331","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:41:48Z","timestamp":1773830508000},"page":"1162-1172","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Update of the\n                    <scp>EuroGuiDerm<\/scp>\n                    evidence\u2010based guideline for the treatment of acne\u2014Short version"],"prefix":"10.1111","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3504-2203","authenticated-orcid":false,"given":"Alexander","family":"Nast","sequence":"first","affiliation":[{"name":"Division of Evidence\u2010Based Medicine, Klinik f\u00fcr Dermatologie Charit\u00e9 \u2010 Universit\u00e4tsmedizin Berlin  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel H.","family":"Al Wattar","sequence":"additional","affiliation":[{"name":"Comprehensive Clinical Trials Unit, Institute of Clinical Trials and Methodology University College London  London UK"},{"name":"Beginnings Assisted Conception Unit Epsom and St Helier University Hospitals  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-1229","authenticated-orcid":false,"given":"Marie","family":"Beylot Barry","sequence":"additional","affiliation":[{"name":"Dermatology Department CHU Bordeaux  Bordeaux France"},{"name":"Universit\u00e9 de Bordeaux  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7433-0190","authenticated-orcid":false,"given":"Holger","family":"Br\u00fcggemann","sequence":"additional","affiliation":[{"name":"Department of Biomedicine Aarhus University  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zrinka","family":"Bukvi\u0107 Mokos","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Centre Zagreb University of Zagreb School of Medicine  Zagreb Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Caruana","sequence":"additional","affiliation":[{"name":"Private Practice  Valletta Malta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Degitz","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Ludwig\u2010Maximilian University  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4832-3410","authenticated-orcid":false,"given":"Clio","family":"Dessinioti","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Andreas Sygros Hospital University of Athens  Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5574-5825","authenticated-orcid":false,"given":"Brigitte","family":"Dr\u00e9no","sequence":"additional","affiliation":[{"name":"INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302\/EMR6001 Nantes Universit\u00e9  Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieke J. B.","family":"Driessen","sequence":"additional","affiliation":[{"name":"Department of Dermatology Radboud University Medical Center  Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-1765","authenticated-orcid":false,"given":"Harald","family":"Gollnick","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology University of Magdeburg  Magdeburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"H\u00e6dersdal","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bispebjerg Hospital University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8189-7486","authenticated-orcid":false,"given":"Alexander","family":"Katoulis","sequence":"additional","affiliation":[{"name":"Second Department of Dermatology and Venereology, Medical School, \u201cAttikon\u201d General University Hospital National and Kapodistrian University of Athens  Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"L\u00e4uchli","sequence":"additional","affiliation":[{"name":"Institute of Dermatology and Venerology Stadtspital Z\u00fcrich  Z\u00fcrich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital of Antwerp University of Antwerp  Antwerp Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Layton","sequence":"additional","affiliation":[{"name":"Skin Research Centre, Hull York Medical School University of York  York UK"},{"name":"Department of Dermatology Harrogate and District NHS Trust  Harrogate UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5157-3939","authenticated-orcid":false,"given":"Giuseppe","family":"Micali","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Catania  Sicily Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk R.","family":"Ochsendorf","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology Goethe\u2010University Frankfurt, Universit\u00e4tsmedizin  Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[{"name":"Department of Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School University of Hull  Hull UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina Zak","family":"Stangeland","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology Aleris Stavanger  Stavanger Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Francis","family":"Thomsen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bispebjerg Hospital University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"T\u00f6r\u00f6csik","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine University of Debrecen  Debrecen Hungary"},{"name":"ELKH\u2010DE Allergology Research Group  Debrecen Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Pennitz","sequence":"additional","affiliation":[{"name":"Division of Evidence\u2010Based Medicine, Klinik f\u00fcr Dermatologie Charit\u00e9 \u2010 Universit\u00e4tsmedizin Berlin  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13776"},{"key":"e_1_2_16_3_1","unstructured":"European Medicines Agency.Changes to the use of antibiotic azithromycin.2025.https:\/\/www.ema.europa.eu\/en\/news\/changes\u2010use\u2010antibiotic\u2010azithromycin"},{"issue":"1","key":"e_1_2_16_4_1","article-title":"Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta\u2010analysis","volume":"2021","author":"Janjua S","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2020.02.012"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50774-1"},{"key":"e_1_2_16_7_1","article-title":"Macrolides versus placebo for chronic asthma","volume":"11","author":"Undela K","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-022-01882-y"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00854-3"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90538-X"},{"key":"e_1_2_16_11_1","unstructured":"European Medicines Agency.Retinoid\u2010containing medicinal products \u2010 referral: Updated measures for pregnancy prevention during retinoid use. Warning on possible risk of neuropsychiatric disorders also to be included for oral retinoids.2018.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/retinoid\u2010containing\u2010medicinal\u2010products"},{"key":"e_1_2_16_12_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X96326"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.028"},{"key":"e_1_2_16_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.11.3.388"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2012.03.005"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002158"},{"key":"e_1_2_16_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.017"},{"issue":"1","key":"e_1_2_16_18_1","first-page":"1","article-title":"Combined hormonal contraception (revision due by January 2024)","volume":"45","author":"FSRH Guideline","year":"2019","journal-title":"BMJ Sex Reprod Health"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70331","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.70331","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:39:09Z","timestamp":1782484749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.70331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1111\/jdv.70331"],"URL":"https:\/\/doi.org\/10.1111\/jdv.70331","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"2025-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}